World Federation of Societies of Anaesthesiologists (WFSA) Signs Commitment to Support Patient Safety Movement’s Mission of Zero Patient Deaths by 2020
The World Federation of Societies of Anaesthesiologists (WFSA) has signed a commitment to action and announced that it will support the Patient Safety Movement Foundation (PSMF) and its mission to eliminate preventable deaths by the year 2020. Concurrently, the PSMF is joining the WFSA’s SAFE-T (Safe Anaesthesia For Everybody – Today) campaign to advance access to safe and affordable anesthesia around the world. The WFSA will formally announce its commitment at the 5th Annual World Patient Safety, Science & Technology Summit, Feb. 3-4, 2017, in Dana Point, California.
Since 1955, WFSA has served as the foremost global alliance of anesthesiologists, working together with national, regional and specialty organizations to facilitate and promote the highest standards of patient care. They work with National Societies of Anaesthesiology, the World Health Organization (WHO), governments, surgical organizations, NGOs, hospitals, training centers, and other organizations to support safe surgery and access to safe anesthesia. Through its network of thousands of anesthesiologists in more than 150 countries, the WFSA will demonstrate their commitment to PSMF’s mission of zero deaths by 2020 by annually disseminating Actionable Patient Safety Solutions (APSS) and asking members working in hospitals to make commitments to reducing preventable patient deaths; updating its International Standards for a Safe Practice of Anaesthesia; and working with the PSMF to develop APSS appropriate for healthcare organizations in low-resource countries.
By joining WFSA’s Safe Anaesthesia For Everybody – Today (SAFE-T) campaign, the PSMF becomes part of a global collaboration of industry and patient-focused organizations and WFSA’s network of anesthesia professionals committed to patient safety and advancing the International Standards for a Safe Practice of Anaesthesia. PSMF also agrees to share available data pertaining to meeting the International Standards globally and to work collaboratively with the WFSA and other consortium members to improve the practice of and access to safe anesthesia.
“We are happy to announce our commitment to action to the Patient Safety Movement. The movement has made a significant impact on patient safety in a short period of time, and we look forward to working together to create APSS for low-resource countries to reduce preventable patient harm and death,” said Dr. Gonzalo Barreiro, President of the World Federation of Societies of Anaesthesiologists. “We also look forward to working with the PSMF on the SAFE-T campaign as we collaborate to ‘map the gap’ in access to safe anaesthesia and use this data to influence advancement in every hospital, and for every patient.”
“The Patient Safety Movement Foundation is excited to formalize its working relationship with the venerable World Federation of Societies of Anaesthesiologists to further our joint mission of improving patient safety and preventing needless surgical deaths throughout the world,” said Joe Kiani, Founder of the Patient Safety Movement Foundation. “WSFA’s vast global network of members is ideally positioned to help us make substantial strides toward our goal of achieving zero patient deaths by 2020. Our team looks forward to working closely with WFSA’s member organizations to advance safer surgical practices and access to anesthesia.”
About The Patient Safety Movement Foundation
More than 200,000 people die every year in U.S. hospitals in ways that could have been prevented. The Patient Safety Movement Foundation was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare, to reduce that number of preventable deaths to 0 by 2020 (0x2020). Improving patient safety will require a collaborative effort from all stakeholders, including patients, healthcare providers, medical technology companies, government, employers, and private payors. The Patient Safety Movement Foundation works with all stakeholders to address the problems and solutions of patient safety. The Foundation also convenes Patient Safety, Science and Technology summits. The first annual Summit was held in January 2013 and brought together some of our nation’s best minds for thought-provoking discussions and new ideas to challenge the status quo. By presenting specific, high-impact recipes to meet patient safety challenges, encouraging medical technology companies to share the data for whom their products are purchased, and asking hospitals to make commitments to implement Actionable Patient Safety Solutions, the Foundation is working toward zero preventable deaths by 2020. Visit http://patientsafetymovement.org/.
@0x2020 #patientsafety #0x2020
Patient Safety Movement Foundation
Irene Paigah, 858-859-7001
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Murex to Offer MX.3 Risk, Trading and Post-Trade Solutions on the AWS Cloud12.12.2017 14:00 | Pressemelding
Murex, an industry leader in trading, risk management and processing solutions for capital markets, announced they will run their MX.3 technology platform on Amazon Web Services, Inc. (AWS). With the acceleration of cloud adoption in capital markets, Murex and AWS agreed to collaborate to help clients migrate their Murex application workloads to the AWS Cloud. Murex clients are looking to consolidate more and more of their capital markets activity on the MX.3 platform and this means their need for infrastructure is increasing. New regulatory requirements are also driving financial organizations to use cloud to scale up their computing capacity. Murex is collaborating with AWS to meet the demand from clients to support deployment of the Murex offering on the AWS Cloud. Murex is working on the validation of a range of deployment scenarios, from using AWS Cloud for bursting grid
Darzalex®▼(daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible12.12.2017 13:33 | Pressemelding
Janssen-Cilag International NV (“Janssen”) today announced data from the Phase 3 ALCYONE study, showing Darzalex® (daratumumab) in combination with bortezomib, melphalan and prednisone (VMP) significantly improved clinical outcomes, including reducing the risk of disease progression or death by 50 percent, in patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation (ASCT).1 These data were accepted as a late-breaking abstract (LBA) for presentation at the 59th American Society of Hematology (ASH) Annual Meeting in Atlanta, today at 7:30 a.m. ET (Abstract #LBA-4).1 Study findings were simultaneously published in the New England Journal of Medicine (NEJM) . 2 Daratumumab is currently indicated for use in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for
CTS Engines Announces Senior Management Hire12.12.2017 13:00 | Pressemelding
CTS Engines, the global leader for mature jet engine maintenance, announced today that it had hired Diane E. Cavuoto as Senior Vice President, Supply Chain, in an effort to continue to provide its customers with outstanding engine overhaul services. Ms. Cavuoto will be based in CTS’s Ft. Lauderdale headquarters and will report directly to Vesa Paukkeri, CTS’s President and Chief Operating Officer. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005050/en/ Diane E. Cavuoto, Senior Vice President, Supply Chain, for CTS Engines (Photo: Business Wire) Ms. Cavuoto, most recently Vice President, Strategic Sourcing at Honeywell International, brings years of supply chain management experience to CTS. In her prior role at Honeywell, Ms. Cavuoto managed a global commodity team of 150 employees managing $4
MIPI Alliance Opens Access to its MIPI I3C Sensor Interface Specification12.12.2017 13:00 | Pressemelding
The MIPI® Alliance, an international organization that develops interface specifications for mobile and mobile-influenced industries, today announced it is opening access to its sensor interface specification, MIPI I3C. Starting today, all companies, including those not currently members of MIPI Alliance, may access the MIPI I3C v1.0 specification so they may evaluate the incorporation of the specification into their sensor integration plans and design applications. “MIPI I3C provides a welcome update to the I2C technology that has been widely adopted over the past 35 years. Extending access provides an opportunity to spur innovation and help other industries beyond mobile," said Joel Huloux, chairman of MIPI Alliance. "It helps MIPI members as well, because it supports greater adoption and interoperability, strengthens the ecosystem and provides for a richer
ADC Therapeutics Announces Interim Phase I Data from its Novel Antibody-Drug Conjugate ADCT-30112.12.2017 11:23 | Pressemelding
ADC Therapeutics (ADCT), an oncology drug discovery and development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers, today announced clinical data from two ongoing Phase I clinical trials evaluating ADCT-301 (camidanlumab tesirine or “Cami-T”) in important subtypes of lymphoma and leukemia. The data were presented at the 59th American Society of Hematology (ASH) Annual Meeting in Atlanta, USA. 1. Interim results of a Phase I open label, single agent, dose-escalating study of ADCT-301 evaluating tolerability, safety, pharmacokinetics and efficacy in patients with relapsed or refractory B-cell Hodgkin’s or non-Hodgkin’s lymphoma Dr. Steven M. Horwitz, Medical Oncologist at Memorial Sloan Kettering Cancer Center in New York City, and Principal Investigator, s
LTI to Offer Blockchain Solution Powered by Microsoft Azure12.12.2017 10:45 | Pressemelding
Larsen & Toubro Infotech Ltd. (NSE: LTI, BSE: 540005), a global technology consulting and digital solutions company, announced today the availability of its blockchain-based trade finance solution on Microsoft Azure marketplace. The solution tracks the flow of goods in a value chain, improving transparency across multiple entities involved. It enables accelerated adoption of distributed ledger technologies by bringing together LTI’s deep industry knowledge and blockchain capabilities together with Microsoft’s expertise in cloud-based solutions. Aftab Ullah, Chief Operating Officer, LTI said, "Our vision is to deliver exponential operational efficiencies to the world’s leading companies through digital innovation. LTI’s Blockchain services include end-to-end consulting and implementation and are designed to help transform our clients’ business operations. The collaboration
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom